Literature DB >> 8840944

Impact of the initial levels of laboratory variables on survival in chronic dialysis patients.

K Iseki1, H Uehara, K Nishime, K Tokuyama, K Yoshihara, K Kinjo, Y Shiohira, K Fukiyama.   

Abstract

Besides the age at start of dialysis and the presence of diabetes mellitus, serum albumin has been shown to be a significant predictor of survival in prevalent dialysis patients. However, this was not evaluated in incipient dialysis patients. The initial biochemical variables were retrieved for a large dialysis population (N = 1,982) who were started on chronic dialysis in Okinawa, Japan from 1971 to 1990. Biochemical data that included blood urea nitrogen, serum creatinine, serum electrolytes (sodium, potassium, calcium, and phosphate), total cholesterol, triglyceride, total protein, serum albumin, and hematocrit obtained just before the first dialysis session were available for 1,491 (75.2%) patients. Six hundred sixty-four (43.2%) patients died by the end of 1993. Cox proportional analysis adjusted for sex, age, year of start of dialysis, presence of diabetes mellitus, and the laboratory variables was performed to examine the significance of the initial biochemical data on survival. The risk ratio was 0.577 (P = 0.0025) in serum albumin, 1.291 (P = 0.0138) in serum potassium, and 0.966 (P = 0.0202) in serum sodium. The study results support the notion that nutritional status is important for survival in chronic dialysis patients. Causes of hypoalbuminemia, hyperkalemia, and hyponatremia should be evaluated carefully at initiation of dialysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8840944     DOI: 10.1016/s0272-6386(96)90465-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  29 in total

Review 1.  How Dangerous Is Hyperkalemia?

Authors:  John R Montford; Stuart Linas
Journal:  J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 10.121

2.  What Is the Meaning of Increased Myocardial Injury Enzymes during Hemodialysis? A Tissue Doppler Imaging Study.

Authors:  Gürsel Yildiz; Mansur Kayataş; Ferhan Candan; Mehmet Birhan Yilmaz; Ali Zorlu; Savaş Sarikaya
Journal:  Cardiorenal Med       Date:  2013-06-25       Impact factor: 2.041

Review 3.  Review article: Biomarkers of clinical outcomes in advanced chronic kidney disease.

Authors:  Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nephrology (Carlton)       Date:  2009-06       Impact factor: 2.506

4.  Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort.

Authors:  Klara Torlén; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Tania Vashistha; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 8.237

5.  Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study.

Authors:  Garland A Campbell; James T Patrie; Bruce D Gaylinn; Michael O Thorner; Warren K Bolton
Journal:  Nephrol Dial Transplant       Date:  2018-03-01       Impact factor: 5.992

Review 6.  Updates in hyperkalemia: Outcomes and therapeutic strategies.

Authors:  Csaba P Kovesdy
Journal:  Rev Endocr Metab Disord       Date:  2017-03       Impact factor: 6.514

7.  Approaches to and Clinical Benefits of Reducing Dietary K in CKD.

Authors:  Jessica Kendrick; Stuart Linas
Journal:  Clin J Am Soc Nephrol       Date:  2017-09-11       Impact factor: 8.237

8.  Dietary potassium intake and mortality in long-term hemodialysis patients.

Authors:  Nazanin Noori; Kamyar Kalantar-Zadeh; Csaba P Kovesdy; Sameer B Murali; Rachelle Bross; Allen R Nissenson; Joel D Kopple
Journal:  Am J Kidney Dis       Date:  2010-06-30       Impact factor: 8.860

9.  Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race.

Authors:  John Hayes; Kamyar Kalantar-Zadeh; Jun L Lu; Sharon Turban; John E Anderson; Csaba P Kovesdy
Journal:  Nephron Clin Pract       Date:  2011-12-02

10.  Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.

Authors:  Csaba P Kovesdy; Kunihiro Matsushita; Yingying Sang; Nigel J Brunskill; Juan J Carrero; Gabriel Chodick; Takeshi Hasegawa; Hiddo L Heerspink; Atsushi Hirayama; Gijs W D Landman; Adeera Levin; Dorothea Nitsch; David C Wheeler; Josef Coresh; Stein I Hallan; Varda Shalev; Morgan E Grams
Journal:  Eur Heart J       Date:  2018-05-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.